Literature DB >> 15681835

Accumulation of filamentous tau in the cerebral cortex of human tau R406W transgenic mice.

Masaki Ikeda1, Mikio Shoji, Toshitaka Kawarai, Takeshi Kawarabayashi, Etsuro Matsubara, Tetsuro Murakami, Atsushi Sasaki, Yasushi Tomidokoro, Yasushi Ikarashi, Hisashi Kuribara, Koichi Ishiguro, Masato Hasegawa, Shu-Hui Yen, M Azhar Chishti, Yasuo Harigaya, Koji Abe, Koichi Okamoto, Peter St George-Hyslop, David Westaway.   

Abstract

Missense mutations of the tau gene cause autosomal dominant frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17), an illness characterized by progressive personality changes, dementia, and parkinsonism. There is prominent frontotemporal lobe atrophy of the brain accompanied by abundant tau accumulation with neurofibrillary tangles and neuronal cell loss. Using a hamster prion protein gene expression vector, we generated several independent lines of transgenic (Tg) mice expressing the longest form of the human four-repeat tau with the R406W mutation associated with FTDP-17. The TgTauR406W 21807 line showed tau accumulation beginning in the hippocampus and amygdala at 6 months of age, which subsequently spread to the cortices and subcortical areas. The accumulated tau was phosphorylated, ubiquitinated, conformationally changed, argyrophilic, and sarcosyl-insoluble. Activation of GSK-3beta and astrocytic induction of mouse tau were observed. Astrogliosis and microgliosis correlated with prominent tau accumulation. Electron microscopic examination revealed the presence of straight filaments. Behavioral tests showed motor disturbances and progressive acquired memory loss between 10 to 12 months of age. These findings suggested that TgTauR406W mice would be a useful model in the study of frontotemporal dementia and other tauopathies such as Alzheimer's disease (AD).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15681835      PMCID: PMC1602315          DOI: 10.1016/S0002-9440(10)62274-2

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  49 in total

1.  Stable expression in Chinese hamster ovary cells of mutated tau genes causing frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).

Authors:  N Matsumura; T Yamazaki; Y Ihara
Journal:  Am J Pathol       Date:  1999-06       Impact factor: 4.307

2.  Phenotypic variation in hereditary frontotemporal dementia with tau mutations.

Authors:  J C van Swieten; M Stevens; S M Rosso; P Rizzu; M Joosse; I de Koning; W Kamphorst; R Ravid; M G Spillantini; P Heutink
Journal:  Ann Neurol       Date:  1999-10       Impact factor: 10.422

3.  Sequence requirements for formation of conformational variants of tau similar to those found in Alzheimer's disease.

Authors:  G A Jicha; B Berenfeld; P Davies
Journal:  J Neurosci Res       Date:  1999-03-15       Impact factor: 4.164

Review 4.  Tau protein pathology in neurodegenerative diseases.

Authors:  M G Spillantini; M Goedert
Journal:  Trends Neurosci       Date:  1998-10       Impact factor: 13.837

5.  Molecular analysis of mutant and wild-type tau deposited in the brain affected by the FTDP-17 R406W mutation.

Authors:  T Miyasaka; M Morishima-Kawashima; R Ravid; P Heutink; J C van Swieten; K Nagashima; Y Ihara
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

6.  Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice.

Authors:  T Ishihara; B Zhang; M Higuchi; Y Yoshiyama; J Q Trojanowski; V M Lee
Journal:  Am J Pathol       Date:  2001-02       Impact factor: 4.307

7.  Abeta amyloidosis induces the initial stage of tau accumulation in APP(Sw) mice.

Authors:  Y Tomidokoro; K Ishiguro; Y Harigaya; E Matsubara; M Ikeda; J M Park; K Yasutake; T Kawarabayashi; K Okamoto; M Shoji
Journal:  Neurosci Lett       Date:  2001-02-23       Impact factor: 3.046

Review 8.  Phenotypic correlations in FTDP-17.

Authors:  L A Reed; Z K Wszolek; M Hutton
Journal:  Neurobiol Aging       Date:  2001 Jan-Feb       Impact factor: 4.673

9.  Tau filament formation in transgenic mice expressing P301L tau.

Authors:  J Götz; F Chen; R Barmettler; R M Nitsch
Journal:  J Biol Chem       Date:  2001-01-05       Impact factor: 5.157

10.  Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17.

Authors:  M Hutton; C L Lendon; P Rizzu; M Baker; S Froelich; H Houlden; S Pickering-Brown; S Chakraverty; A Isaacs; A Grover; J Hackett; J Adamson; S Lincoln; D Dickson; P Davies; R C Petersen; M Stevens; E de Graaff; E Wauters; J van Baren; M Hillebrand; M Joosse; J M Kwon; P Nowotny; L K Che; J Norton; J C Morris; L A Reed; J Trojanowski; H Basun; L Lannfelt; M Neystat; S Fahn; F Dark; T Tannenberg; P R Dodd; N Hayward; J B Kwok; P R Schofield; A Andreadis; J Snowden; D Craufurd; D Neary; F Owen; B A Oostra; J Hardy; A Goate; J van Swieten; D Mann; T Lynch; P Heutink
Journal:  Nature       Date:  1998-06-18       Impact factor: 49.962

View more
  45 in total

1.  Neurogenesis in Alzheimer´s disease: a realistic alternative to neuronal degeneration?

Authors:  Rocío E Gonzalez-Castaneda; Alma Y Galvez-Contreras; Sonia Luquín; Oscar Gonzalez-Perez
Journal:  Curr Signal Transduct Ther       Date:  2011-09-01

2.  Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain.

Authors:  Nicole Maphis; Guixiang Xu; Olga N Kokiko-Cochran; Shanya Jiang; Astrid Cardona; Richard M Ransohoff; Bruce T Lamb; Kiran Bhaskar
Journal:  Brain       Date:  2015-03-31       Impact factor: 13.501

Review 3.  Single cell gene expression profiling in Alzheimer's disease.

Authors:  Stephen D Ginsberg; Shaoli Che; Scott E Counts; Elliott J Mufson
Journal:  NeuroRx       Date:  2006-07

4.  Alzheimer's disease-like tau neuropathology leads to memory deficits and loss of functional synapses in a novel mutated tau transgenic mouse without any motor deficits.

Authors:  Katharina Schindowski; Alexis Bretteville; Karelle Leroy; Séverine Bégard; Jean-Pierre Brion; Malika Hamdane; Luc Buée
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

Review 5.  Knock-out and transgenic mouse models of tauopathies.

Authors:  Franziska Denk; Richard Wade-Martins
Journal:  Neurobiol Aging       Date:  2007-06-22       Impact factor: 4.673

6.  Development of a water-escape motivated version of the Stone T-maze for mice.

Authors:  P J Pistell; D K Ingram
Journal:  Neuroscience       Date:  2009-12-22       Impact factor: 3.590

7.  Age-associated learning and memory deficits in two mouse versions of the Stone T-maze.

Authors:  Paul J Pistell; Edward L Spangler; Bennett Kelly-Bell; Marshall G Miller; Rafael de Cabo; Donald K Ingram
Journal:  Neurobiol Aging       Date:  2012-01-02       Impact factor: 4.673

8.  Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity.

Authors:  Cliona Stack; Shari Jainuddin; Ceyhan Elipenahli; Meri Gerges; Natalia Starkova; Anatoly A Starkov; Mariona Jové; Manuel Portero-Otin; Nathalie Launay; Aurora Pujol; Navneet Ammal Kaidery; Bobby Thomas; Davide Tampellini; M Flint Beal; Magali Dumont
Journal:  Hum Mol Genet       Date:  2014-02-20       Impact factor: 6.150

9.  Spatial learning impairments in PLB1Triple knock-in Alzheimer mice are task-specific and age-dependent.

Authors:  D Ryan; D Koss; E Porcu; H Woodcock; L Robinson; B Platt; G Riedel
Journal:  Cell Mol Life Sci       Date:  2013-03-28       Impact factor: 9.261

Review 10.  Improved behavioral response as a valid biomarker for drug screening program in transgenic rodent models of tauopathies.

Authors:  Miroslava Korenova; Zuzana Stozicka
Journal:  Cell Mol Neurobiol       Date:  2009-03-13       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.